Delivery Order SPE2DB20D3103-SPE2DB22FN7P5
- Not listed
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,873.44, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 8, 2025 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops with a ceiling value of $15,405.59. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of September 5, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,727.14 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 9, 2022, with a completion date of December 12, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Vigamox 0.5% eye drops to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $8,144.34 and an Ultimate Completion Date of September 23, 2021. This contract is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops, with a ceiling value of $3,854.27. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 11, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops with a 3ml volume, valued at $5,616.54. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with an ultimate completion date of June 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $11,090.20, is for the delivery of VIGAMOX 0.5% eye drops in 3ml containers. The contract is a Firm Fixed Price Delivery Order with a completion date of May 7, 2024. The award was made on May 6, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor...
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,738.87 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The delivery order, valued at $3,796.14, is for the procurement of VIGAMOX 0.5% Eye Drops 3ML. The contract has a firm fixed price and an ultimate completion date of March 9, 2023. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award, valued at $3,748.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, with a completion date of February 12, 2025. This is a firm fixed-price delivery order contract, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN7P5Delivery Order
This federal contract award is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $12,422.06 and has a firm fixed price pricing type. The award date is May 26, 2022, and the ultimate completion date is May 27, 2022. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, that serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 5/26/22 |